/
Other
8.8KDiseases↗
10.5KPipeline Programs↗
19.3KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
100,125
clinical trials
Completed58,876 · 59%
Unknown status11,679 · 12%
Recruiting10,070 · 10%
Terminated6,458 · 6%
Not yet recruiting5,251 · 5%
Active, not recruiting3,283 · 3%
Other4,508 · 5%
Landscape
Diseases
TED
Most programs0
Programs
4,000
Trials
23
Recruiting
AIN
Most trials0
Programs
2,449
Trials
17
Recruiting
MPA
Highest activity0
Programs
2,322
Trials
19
Recruiting
ILD
0 programs1194 trials
Tics
11 program1182 trialsApproved
CLE
0 programs1010 trials
TIA
0 programs879 trials
SCLC
10 programs823 trialsPhase 1
NSCLC
50 programs711 trialsPhase 3
Prostate CA
0 programs647 trials
Pancreatic
10 programs558 trialsPhase 1
Colorectal
10 programs546 trialsPhase 2
POI
0 programs508 trials
SLE
0 programs498 trialsPhase 2
ACL
0 programs447 trials
Ovarian
20 programs446 trialsPhase 3
OSA
0 programs425 trials
STEMI
0 programs409 trials
Coma
0 programs361 trialsPreclinical
AML
20 programs337 trialsPhase 3
Fibrosis
101 programs223 trialsApproved
MCI
30 programs268 trials
Durvalumab
0 programs246 trials
Adjuvant Treatment
0 programs243 trials
Anesthesia
30 programs234 trialsApproved
Bone
30 programs234 trialsPhase 2
Gemcitabine
0 programs229 trials
Elderly
0 programs228 trialsApproved
Biomarker
0 programs228 trials
Chemoradiotherapy
0 programs225 trials
Showing top 30 diseases by activity. 8726 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)